Health technology company PicnicHealth has revealed its move into the field of oncology, collaborating with AstraZeneca to establish a registry aimed at generating real-world data concerning breast cancer.

In a significant multiyear partnership, PicnicHealth intends to develop a registry that collects longitudinal real-world data from consenting patients in the United States who have been diagnosed with stage 1 to stage 3 breast cancer. Patients can currently enroll in this registry, which will compile their medical records into a centralized platform. This platform allows patients to anonymously share their data for the purposes of breast cancer research.

This move aligns with PicnicHealth’s previous partnerships and initiatives. The company recently collaborated with Roche and its subsidiary Genentech to accelerate research into neurological diseases using real-world data, particularly in relation to Alzheimer’s Disease and related conditions.

Article written by  Jessica Hagen



Mobi Health News